topotecan hydrochloride [clinicaltrials_resource:1b6c7fa5ff287c7df693003f014e15da]
intervention [clinicaltrials_vocabulary:intervention]
topotecan hydrochloride [clinicaltrials_resource:1b6c7fa5ff287c7df693003f014e15da]
Bio2RDF identifier
1b6c7fa5ff287c7df693003f014e15da
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:1b6c7fa5ff287c7df693003f014e15da
arm group [clinicaltrials_vocabulary:arm-group]
intervention desc [clinicaltrials_vocabulary:intervention-desc]
intravenously (IV) over 30 minutes on days 1, 8, 15, 22, and 29.
intervention name [clinicaltrials_vocabulary:intervention-name]
topotecan hydrochloride
other name [clinicaltrials_vocabulary:other-name]
Hycamtin(R)
identifier
clinicaltrials_resource:1b6c7fa5ff287c7df693003f014e15da
title
topotecan hydrochloride
@en
type
label
topotecan hydrochloride [clinicaltrials_resource:1b6c7fa5ff287c7df693003f014e15da]
@en